BackAdvagene Biopharma , Ltd. Overview

Advagene Biopharma , Ltd. Total Liabilities

Track Advagene Biopharma , Ltd.'s total liabilities ($9.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.60M
↓ 2.07% YoYΔ $-203000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Advagene Biopharma , Ltd. Total Liabilities History

Loading

Advagene Biopharma , Ltd. vs. peers: Total Liabilities Comparison

Loading

Advagene Biopharma , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Advagene Biopharma , Ltd. (6709.TWO) FAQ

As of the most recent data (June 2026), 6709.TWO shows a total liabilities of $9.6M. That compares with $9.8M in the prior-year period — down 2.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6709.TWO's total liabilities is now $9.6M (was $9.8M) — a 2.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Advagene Biopharma , Ltd. is outperforming or lagging.

Tracking 6709.TWO's total liabilities over time shows whether Advagene Biopharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $9.6M That compares with $9.8M in the prior-year period — down 2.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Advagene Biopharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $9.6M) with ownership activity and broader fundamentals.

Advagene Biopharma , Ltd.'s total liabilities is $9.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.